Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · IEX Real-Time Price · USD
32.23
+0.51 (1.61%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Revolution Medicines Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017
Net Income
-436.37-248.71-187.09-110.38-61.9-48.82-34.89
Depreciation & Amortization
9.319.667.336.553.341.761.19
Share-Based Compensation
61.7731.220.728.893.160.860.14
Other Operating Activities
14.71-16.5511.86-7.34-8.4640.384.65
Operating Cash Flow
-350.57-224.4-147.18-100.06-49.621.21-25.15
Capital Expenditures
-7.73-10.82-6.53-2.93-2.39-1.5-1.58
Acquisitions
000000.160
Change in Investments
-334.87-13.3-135.59-231.3-105.5800
Other Investing Activities
----6--
Investing Cash Flow
-342.6-24.12-142.12-234.23-101.97-1.34-1.58
Share Issuance / Repurchase
392.39301.39294.6422.780.230.290.07
Other Financing Activities
836.810.04-0.42-98.4360.5622.59
Financing Cash Flow
1,229301.43294.18422.7898.6660.8522.66
Net Cash Flow
536.0352.924.8888.48-52.9360.72-4.06
Free Cash Flow
-358.3-235.22-153.71-103-52.01-0.29-26.72
Free Cash Flow Margin
-3094.14%-664.83%-522.99%-239.62%-103.93%-1.42%-
Free Cash Flow Per Share
-3.17-2.92-2.11-1.88-18.76-0.12-15.51
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).